In today’s complex Healthcare regulatory landscape, the FDA is already using AI (like ELSA, launched last July) to scan for violations 24/7. To stay ahead, your brand needs more than just a checklist - it needs comprehensive, automated protection.
Elpida | 11.08.26
The era of manual Medical-Legal-Regulatory (MLR) review is over.
Elpida has pioneered a Bi-Directional Compliance Infrastructure – a shield that works in both directions, 24/7.
What does “Bi-Directional” actually mean for your brand?
-
Outside-In Protection: Elpida continuously scans assets of any type – text, image, and video – against newly published federal, state, and platform (Meta, Google, etc.) regulations. If the rules change, we catch the gap before the regulators do.
-
Inside-Out Integrity: Elpida monitors every change made to branded assets by partners or teams, verifying them against current rules and standards in real-time.
Stop reactive firefighting. Elpida ensures that when regulations shift or assets iterate, your brand remains bulletproof. It’s not just monitoring; it’s automated, documented, and proactive enforcement.
More from Elpida
-
Compliance AI – The Future
Ben-Ari Kutai, Elpida CTO | Feb 15 2026
The future of AI compliance isn’t a smarter model, it’s stronger organizational memory. Elpida captures your legal team’s decisions as reusable skills, building a compliance layer that gets smarter over time and safeguards every claim before it goes live.
Read more -
The Elpida Shield In Action – The Crash – Test Case 02
Elpida | Feb 15 2026
A brain-wellness startup’s “move fast” marketing triggered an FDA Warning Letter and an 85% revenue drop. Elpida’s Shield would have blocked risky claims at draft stage, enabling zero-risk scaling, protected valuation, and total confidence under AI surveillance.
Read more
